Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch

Clinical trial NCT01902992 · COMPLETED

Trial details

NCT number: NCT01902992
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Rhinoconjunctivitis

Start date: 2012-03-01
Primary completion: 2012-07-01
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.